Subscribe for perks & to support LI

Your Interests & Preferences: Personalise your reading

Which best describes your role and/or interests?

I work in a law firm
I work for a company / in-house
I'm a litigator at the bar
I'm a law student
Aspiring law student
Other
Save setting
Or click here to show more preferences...

I am interested in the following types of stories (uncheck to hide from frontpage)

Firms / In-House
Deals
Courts
Legal Education

Always show me: (overrides the above)

Exclusives & Editor's Picks

Website Look & Feel

Light Text on Dark Background

Save preferences


Note: Your preferences will be saved in your browser. You can always change your settings by clicking the Your Preferences button at the top of every page.

Reset preferences to defaults?

Veritas, Khaitan on $100m Recipharm infusion in Nitin Lifesciences

Veritas Legal advised Recipharm AB, a Swedish pharmaceutical company on investing $103m (Rs 671.2 crore) in Nitin Lifesciences, an Indian pharma company which was advised by Khaitan & Co.

Veritas partner Partner Nandish Vyas and Associates Natasha Sethna and Tejasvi Saxena acted for Recipharm.

Khaitan Mumbai partner Kalpana Unadkat, senior associate Shweta Dwivedi and associate Bidya Mohanty acted for Nitin Lifesciences.

Recipharm, will buy 74 per cent in Nitin Lifesciences, reported Livemint


Latest comments